AI evidence summary · MVP
Taurine for Endurance
AI preliminary evidence assessment
CC 級|AI 整體初步評級
This preliminary assessment is currently available in Traditional Chinese.
Exact question對成人,口服單一牛磺酸相較安慰劑或其他條件相同的同期對照,是否改善實際耐力測驗表現,並有哪些不良反應?急性與長期補充、訓練程度、計時測驗與運動至力竭分層呈現。
已有直接研究,但結果不一致;部分急性補充研究觀察到改善,另有研究未見改善或只在特定劑量、性別與環境下出現差異,目前不足以支持一般成人耐力表現穩定改善。保留18份直接研究報告,目前確認至少2個不同試驗事件、16份群體關係未明;計分僅使用已確認研究列。
Additional assessment reasons await presentation; see the research results below.
Limitations affecting this assessment
- 計分方法、缺值政策與門檻請見頁末統一方法說明;中性政策值不是研究支持票,也不表示沒有系統性回顧。
- 本次為有界 PubMed 檢索:136筆完整篩選,保留18份直接研究與59份背景來源;並非全球完整證據。
- 18份直接報告的臨床結果均保留,目前確認至少2個不同試驗事件、16份群體關係未明。現行計分只使用已確認研究列,可能影響方向及資助比例;未確認不代表沒有研究或陰性,交叉期與多臂不增加群體,也不能加總唯一受試者。
- 直接研究僅 PMID 27380030、41158650取得全文,其餘多為摘要,偏倚、退出及次要結果核查受限。部分報告有參與人數但未交代招募或完成流程,僅保留報告人數。
- PMID 29472738僅固定負荷經濟性,不能代表耐力改善;25833487無可評讀摘要,39561745勘誤未讀,無法確認是否影響39419489的結果。
- 未知資助、劑量與不良事件維持未知;無利益衝突聲明不等於無資助,未報不良事件不等於零事件或長期安全。
- PMID 35213817複方背景來源本次未生成有效摘要,僅保留原文標題與連結;PMID 32330107的運動前15分鐘不是可確認的持續時間,該欄位留空。其他背景必要欄位支持不足者未列讀者結果,未據此生成單方療效宣稱。
- 計時測驗、運動至力竭、末端功率及後續衝刺不能混讀;脂肪氧化與生物標記改善不等於耐力改善。急性/長期、訓練程度及冷熱環境分開;咖啡因、肌酸等複方陽性不能歸因單方,僅採相同背景的純方對比。
- 2018統合分析(PMID 29546641)單方耐力 g=0.40(95%信賴區間0.12–0.67),力竭測驗 g=0.43(0.12–0.75);10篇文章/7篇力竭研究不等於額外獨立群體。2025分析(PMID 40852891)整體運動 g=0.25(0.10–0.39),混合耐力、力量及敏捷,證據確定性低或極低、預測區間常含無效值,敏感度分析部分減弱。兩者納入表未取得,不能另加證據池;PMID 34497536亦涵蓋代謝代理及力量,非專屬計時/力竭統合結果。
- PMID 41158650僅4克有顯著效益,1及6克沒有;自由度、16人敘述與討論百分比存在不一致,不能確立最佳劑量。PMID 42245559熱環境結果依劑量及性別而異,16人中的男女各8人不是額外群體,且登錄為回溯性。
Research results
Findings are currently provided in Traditional Chinese; source excerpts retain their original language.
Main result 1
單次,運動前1小時三條件TT表現無差異,所報平均時間1,500±87秒。90分鐘內總脂肪氧化增加16%,但未轉化為實際耐力效益。
Applicability assessment: 急性單方牛磺酸與對照比較;先騎乘90分鐘再計時。
- Population
- 完成試驗的耐力訓練男性自行車選手11人
- Intervention
- 口服1.66克牛磺酸
- Comparator
- 安慰劑及控制條件
- Outcome
- 自行車計時測驗表現
- Follow-up
- 單次,運動前1小時
- Formulation
- Not established
- Dose
- 單次1.66克,運動前1小時
Source excerpt: There was no difference in TT performance between any of the 3 trials (1,500 ± 87 s).View source
Main result 2
單次,測驗前2小時3公里TT為646.6±52.8對658.5±58.2秒,p=0.013;來源報改善1.7%。心率、費力感、乳酸與相對耗氧未有差異。
Applicability assessment: 急性單方牛磺酸與安慰劑比較,測量3公里跑步計時。
- Population
- 完成試驗的受訓男性中距離跑者8人
- Intervention
- 口服1,000毫克牛磺酸
- Comparator
- 安慰劑膠囊
- Outcome
- 3公里跑步計時測驗
- Follow-up
- 單次,測驗前2小時
- Formulation
- Not established
- Dose
- 單次1,000毫克,測驗前2小時
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 3
單次飲用;運動前間隔未提供包含單方牛磺酸與安慰劑的各條件比較未見測驗差異;安慰劑力竭時間17±1.2分鐘。摘要未列單方差值或信賴區間。
Applicability assessment: 五條件試驗含可分離的單方牛磺酸與安慰劑。
- Population
- 報告14名男性軍人;參與者流程角色未明
- Intervention
- 含1,000毫克牛磺酸的250毫升飲料
- Comparator
- 感官性質匹配的安慰劑飲料
- Outcome
- 運動至力竭時間等體能測驗
- Follow-up
- 單次飲用;運動前間隔未提供
- Formulation
- Not established
- Dose
- 單次1,000毫克,250毫升飲料;確切運動前間隔未提供
Source excerpt: Comparisons among the commercial drink, caffeine, taurine, caffeine plus taurine and placebo treatments did not show statistically differences in the results of the performed tests.View source
Main result 4
急性單次;運動前間隔未提供高強度跑步TTE所列兩條件237.70±66.00及277.30±40.64秒,p=0.44,未達顯著;氧虧指標亦未有顯著差異。
Applicability assessment: 急性單方牛磺酸與安慰劑比較,測量超最大強度跑步至力竭。
- Population
- 完成初始漸增測驗的健康男性17人
- Intervention
- 口服6克牛磺酸
- Comparator
- 6克葡萄糖安慰劑
- Outcome
- 高強度跑步至力竭時間
- Follow-up
- 急性單次;運動前間隔未提供
- Formulation
- Not established
- Dose
- 急性6克;摘要未提供確切服用至運動間隔
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 5
單次,測驗前2小時4公里TT為牛磺酸390±27、安慰劑388±21秒,p=0.731;全文配對差值1.87秒,95% CI −9.89至13.63秒。未見配速、耗氧或緩衝指標效益。
Applicability assessment: 急性單方牛磺酸與安慰劑比較,測量4公里自行車計時。
- Population
- 報告11名受訓男性自行車選手;參與者流程角色未明
- Intervention
- 口服1,000毫克牛磺酸
- Comparator
- 500毫升水
- Outcome
- 4公里自行車計時測驗
- Follow-up
- 單次,測驗前2小時
- Formulation
- Not established
- Dose
- 單次1,000毫克,500毫升水,測驗前2小時
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 6
8週漸增跑步測驗有氧參數未改善;牛磺酸條件Vmax由13±1.4至13.22±1.34公里/小時,牛奶對照由13.11±2.34至13.11±2.72。氧化壓力及氮代謝變化不作表現效益。
Applicability assessment: 8週補充,牛磺酸與安慰劑條件均有巧克力牛奶背景。
- Population
- 男性鐵人三項運動員;驗證人數未提供
- Intervention
- 運動後3克牛磺酸加400毫升巧克力牛奶
- Comparator
- 巧克力牛奶安慰劑
- Outcome
- 漸增跑步測驗的有氧參數
- Follow-up
- 8週
- Formulation
- Not established
- Dose
- 運動後3克牛磺酸加400毫升巧克力牛奶,持續8週;摘要未明示每日頻次
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 7
單次,游泳前120分鐘400公尺游泳表現未改善;甘油、乳酸變化及供能比例改變均不能視為游泳耐力效益。
Applicability assessment: 單方牛磺酸與安慰劑比較,測量400公尺游泳表現。
- Population
- 報告9名男性競技游泳選手;參與者流程角色未明
- Intervention
- 口服6克牛磺酸
- Comparator
- 安慰劑
- Outcome
- 400公尺自由式最大努力表現
- Follow-up
- 單次,游泳前120分鐘
- Formulation
- Not established
- Dose
- 單次6克,游泳前120分鐘
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 8
急性攝取;服用時間未列漸增力竭測驗末端功率較高,條件效應P<0.001;其後第2至6次衝刺峰值功率反而在安慰劑較高。不能將短測驗末端功率改善推為持續耐力或衝刺全面受益。
Applicability assessment: 女性在漸增騎車力竭後接受反覆衝刺測驗。
- Population
- 完成測驗的女性9人
- Intervention
- 50毫克/公斤牛磺酸
- Comparator
- 匹配踏頻的麥芽糊精安慰劑
- Outcome
- 漸增測驗末端功率及後續衝刺峰值功率
- Follow-up
- 急性攝取;服用時間未列
- Formulation
- Not established
- Dose
- 急性50毫克/公斤;摘要未列確切服用時間
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 9
單次,運動前2小時熱環境TTE為25.16對22.43分鐘,p=0.040;來源報增加10%。局部出汗增加,後期費力感及核心溫度降低;結果限此熱環境TTE。
Applicability assessment: 急性單方牛磺酸與安慰劑比較,測量熱環境自行車力竭時間。
- Population
- 納入試驗的健康男性11人
- Intervention
- 50毫克/公斤牛磺酸
- Comparator
- 麥芽糊精安慰劑
- Outcome
- 熱環境自行車運動至力竭時間
- Follow-up
- 單次,運動前2小時
- Formulation
- Not established
- Dose
- 單次50毫克/公斤,運動前2小時
Source excerpt: Taurine supplementation increased time to exhaustion by 10% (25.16 min vs. 22.43 min, p = 0.040)View source
Main result 10
急性攝取;測驗前間隔未列牛磺酸臨界功率212±36瓦、安慰劑193±35瓦,P<0.05;實測TTE為17.7對16.0分鐘,延長1.7分鐘,P<0.05。各目標工作量Tlim為估算,非新增實測TT。
Applicability assessment: 單方牛磺酸與安慰劑比較,含實測自行車力竭時間。
- Population
- 完成基線測驗的男性12人
- Intervention
- 50毫克/公斤牛磺酸
- Comparator
- 麥芽糊精安慰劑
- Outcome
- 高於臨界功率5%的實測力竭時間
- Follow-up
- 急性攝取;測驗前間隔未列
- Formulation
- Not established
- Dose
- 急性50毫克/公斤;摘要未列服用至測驗間隔
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 11
單次,測驗前2小時TTE為14.6±4.7對13.4±5.6分鐘,P=0.061,未達顯著;不能以接近門檻或舒適感、代謝差異宣稱耐力改善。
Applicability assessment: 急性單方牛磺酸與安慰劑比較,測量冷環境騎車力竭時間。
- Population
- 報告11名男性;參與者流程角色未明
- Intervention
- 50毫克/公斤牛磺酸
- Comparator
- 安慰劑飲料
- Outcome
- 冷環境自行車運動至力竭時間
- Follow-up
- 單次,測驗前2小時
- Formulation
- Not established
- Dose
- 單次50毫克/公斤,測驗前2小時
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 12
急性攝取;劑量與間隔未列摘要明示單方TAU、CAF及合併條件均較安慰劑改善TTE,因此保留單方陽性;未列單方TTE均數、差值、CI或專屬p值,不能量化幅度。
Applicability assessment: 四條件試驗包含可分離的牛磺酸單方與安慰劑。
- Population
- 納入試驗的體育系大學生12人
- Intervention
- 牛磺酸單方
- Comparator
- 麥芽糊精安慰劑
- Outcome
- 高溫高濕環境運動至力竭時間
- Follow-up
- 急性攝取;劑量與間隔未列
- Formulation
- Not established
- Dose
- 急性單方;確切劑量與服用間隔未提供
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 13
單次,運動前90分鐘TTE為1,444.8±88.6對1,447.6±87.34秒,p=.65、d=−0.04,未改善。MFO、FATmax與VO2peak亦未顯著改善;固定強度跑步耗氧增加不作耐力效益。
Applicability assessment: 單次牛磺酸與安慰劑比較,含漸增跑步力竭時間。
- Population
- 報告11名休閒訓練男性耐力跑者;參與者流程角色未明
- Intervention
- 口服6克牛磺酸
- Comparator
- 安慰劑
- Outcome
- 漸增跑步運動至力竭時間
- Follow-up
- 單次,運動前90分鐘
- Formulation
- Not established
- Dose
- 單次6克,運動前90分鐘
Source excerpt: TTE was not significantly altered (TAU: 1,444.8 ± 88.6 s; PLA: 1,447.6 ± 87.34 s; p = .65, d = -0.04).View source
Main result 14
急性攝取;服用間隔未列摘要僅明示CAF及TAU+CAF的TTE改善,未列純TAU對安慰劑的TTE數值或p值,故純單方耐力對比不明,不能推定陽性或確定陰性。TAU跳躍改善為非耐力終點。
Applicability assessment: 含單方牛磺酸條件,但所引力竭結果只列咖啡因及複方。
- Population
- 納入試驗的受訓男性大學足球員16人
- Intervention
- 50毫克/公斤單方牛磺酸
- Comparator
- 麥芽糊精安慰劑
- Outcome
- 模擬低氧環境的運動至力竭時間
- Follow-up
- 急性攝取;服用間隔未列
- Formulation
- Not established
- Dose
- 急性50毫克/公斤;確切服用間隔未提供
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 15
僅TAU+Cr對安慰劑TTE顯著,P=.04;單方TAU對安慰劑TTE未列專屬估計,保留不明。反覆衝刺組間無差異;不可把複方TTE效益歸於單方。
Applicability assessment: 有單方牛磺酸條件,但所引力竭結果僅是牛磺酸加肌酸複方。
- Population
- 隨機分派的體育學生12人
- Intervention
- 單方牛磺酸條件,劑量未列
- Comparator
- 安慰劑
- Outcome
- 熱環境運動至力竭時間
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- 來源未提供單方劑量、服用間隔或療程
Source excerpt: TTE was significantly higher in the T+C group than in the P group (P = 0.04).View source
Main result 16
單次,運動前1小時4克TTE為812.38±90.948秒,安慰劑702.38±83.088秒,配對比較p=.031;1克754.81±125.378及6克760.44±121.962秒未達顯著。三劑量屬同一隊列,不能概括所有劑量有效。
Applicability assessment: 同一交叉試驗比較三種單方牛磺酸劑量與安慰劑。
- Population
- 納入試驗的男性體育系大學生16人
- Intervention
- 1、4或6克牛磺酸,分別測試
- Comparator
- 麥芽糊精安慰劑
- Outcome
- 高溫高濕環境漸增騎車至力竭時間
- Follow-up
- 單次,運動前1小時
- Formulation
- Not established
- Dose
- 單次1、4或6克,300毫升水,運動前1小時
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 17
急性單次;服用間隔未列男性6克對安慰劑、女性4克對安慰劑的力竭時間較長,P<.05。後續衝刺亦具性別及劑量差異;摘要未提供所有對比、均數或CI,不能宣稱全體或全部劑量有效。
Applicability assessment: 單方牛磺酸多劑量交叉試驗,按性別報告力竭時間。
- Population
- 納入試驗的大學生16人,男女各8人
- Intervention
- 1、4或6克牛磺酸,分別測試
- Comparator
- 安慰劑
- Outcome
- 高溫高濕環境運動至力竭時間
- Follow-up
- 急性單次;服用間隔未列
- Formulation
- Not established
- Dose
- 急性單次1、4或6克;確切運動前間隔未提供
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceMain result 18
單次,測驗前1小時TTE p=.361,未顯著改善;峰值耗氧、呼吸代償點與脂質及糖解代謝指標亦未顯著改變。摘要未列TTE差值與CI。
Applicability assessment: 急性單方牛磺酸與安慰劑交叉比較,含漸增心肺測驗力竭時間。
- Population
- 納入試驗的身體活動年輕成人16人,女性11人、男性5人
- Intervention
- 口服1克牛磺酸
- Comparator
- 安慰劑膠囊
- Outcome
- 漸增心肺運動測驗至力竭時間
- Follow-up
- 單次,測驗前1小時
- Formulation
- Not established
- Dose
- 單次1克,測驗前1小時
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceAdditional finding 19
研究將觀察到的表現變化歸於成分組合。
Applicability assessment: 能量飲料含多種成分,不能歸因於單一牛磺酸。
- Population
- 報告共36名志願者,分布於3項研究。
- Intervention
- 含牛磺酸、葡萄糖醛酸內酯與咖啡因的紅牛能量飲料
- Comparator
- 對照飲料
- Outcome
- 身體耐力
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- Not established
Source excerpt: These consistent and wide ranging improvements in performance are interpreted as reflecting the effects of the combination of ingredients.View source
Safety finding 20
單次飲用;運動前間隔未提供參與者未回報不良反應;未提供分條件事件數、主動監測方法或長期追蹤,不能據此確認長期安全。
Applicability assessment: 同一試驗中參與者的不良反應回報。
- Population
- 報告14名男性軍人;參與者流程角色未明
- Intervention
- 含1,000毫克牛磺酸的250毫升飲料
- Comparator
- 安慰劑飲料
- Outcome
- 參與者回報的不良反應
- Follow-up
- 單次飲用;運動前間隔未提供
- Formulation
- Not established
- Dose
- 單次1,000毫克,250毫升飲料;確切運動前間隔未提供
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceSafety finding 21
急性攝取;服用時間未列後續衝刺表現受損為實測不利表現結果;非已驗證的臨床不良事件。摘要未提供症狀或事件數。
Applicability assessment: 同一試驗記錄後續衝刺表現的不利變化。
- Population
- 完成測驗的女性9人
- Intervention
- 50毫克/公斤牛磺酸
- Comparator
- 安慰劑
- Outcome
- 後續反覆衝刺表現
- Follow-up
- 急性攝取;服用時間未列
- Formulation
- Not established
- Dose
- 急性50毫克/公斤;摘要未列確切服用時間
Source excerpt: Taurine-lowered pre-exercise HR and improved incremental end-test power output, with subsequent detrimental effects on sprint performance, independent of cadence.View source
Additional finding 22
研究測試複方運動前補充品。
Applicability assessment: 運動前補充品含酮鹽、咖啡因及胺基酸。
- Population
- 兩種飲食背景的休閒活動成人
- Intervention
- 含酮鹽、咖啡因、白胺酸與牛磺酸的複方
- Comparator
- 水
- Outcome
- 自行車運動至力竭時間
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- Not established
Source excerpt: We tested the performance and metabolic effects of a pre-workout supplement containing beta-hydroxybutyrate (BHB) salts, caffeine, and amino acids (KCA)View source
Safety finding 23
單方條件乳酸與鼓膜溫度峰值高於安慰劑,分別P=.04及P<.01;為潛在不利生理訊號,未報臨床症狀、事件數或嚴重程度。
Applicability assessment: 單方牛磺酸條件與安慰劑比較,記錄乳酸與鼓膜溫度峰值。
- Population
- 隨機分派的體育學生12人
- Intervention
- 單方牛磺酸條件,劑量未列
- Comparator
- 安慰劑
- Outcome
- 血乳酸及鼓膜溫度峰值
- Follow-up
- Not established
- Formulation
- Not established
- Dose
- 來源未提供單方劑量、服用間隔或療程
No additional short excerpt is shown for this finding. See the linked source to check the result.
View sourceSources consulted
- The effects of red bull energy drink on human performance and mood. Context source; not counted as an included human-result report Abstract only · 2026-10-06T07:55:26.676825Z
- The effect of acute taurine ingestion on endurance performance and metabolism in well-trained cyclists. Abstract only · 2026-10-06T07:55:26.676825Z
- The effect of acute taurine ingestion on 3-km running performance in trained middle-distance runners. Abstract only · 2026-10-06T07:55:26.676825Z
- Effects of energy drink major bioactive compounds on the performance of young adults in fitness and cognitive tests: a randomized controlled trial. Abstract only · 2026-10-06T07:55:26.676825Z
- Acute administration of high doses of taurine does not substantially improve high-intensity running performance and the effect on maximal accumulated oxygen deficit is unclear. Abstract only · 2026-10-06T07:55:26.676825Z
- The effect of acute taurine ingestion on 4-km time trial performance in trained cyclists. Full text · 2026-10-06T07:55:26.676825Z
- Taurine: A Potential Ergogenic Aid for Preventing Muscle Damage and Protein Catabolism and Decreasing Oxidative Stress Produced by Endurance Exercise. Abstract only · 2026-10-06T07:55:26.676825Z
- Taurine supplementation can increase lipolysis and affect the contribution of energy systems during front crawl maximal effort. Abstract only · 2026-10-06T07:55:26.676825Z
- The Effects of an Oral Taurine Dose and Supplementation Period on Endurance Exercise Performance in Humans: A Meta-Analysis. Context source; not counted as an included human-result report Abstract only · 2026-10-06T07:55:26.676825Z
- The effects of taurine on repeat sprint cycling after low or high cadence exhaustive exercise in females. Abstract only · 2026-10-06T07:55:26.676825Z
- Acute taurine supplementation enhances thermoregulation and endurance cycling performance in the heat. Abstract only · 2026-10-06T07:55:26.676825Z
- Oral taurine improves critical power and severe-intensity exercise tolerance. Abstract only · 2026-10-06T07:55:26.676825Z
- A Pre-Workout Supplement of Ketone Salts, Caffeine, and Amino Acids Improves High-Intensity Exercise Performance in Keto-Naïve and Keto-Adapted Individuals. Context source; not counted as an included human-result report Abstract only · 2026-10-06T07:55:26.676825Z
- Physiological and thermoregulatory effects of oral taurine supplementation on exercise tolerance during forced convective cooling. Abstract only · 2026-10-06T07:55:26.676825Z
- The Dose Response of Taurine on Aerobic and Strength Exercises: A Systematic Review. Context source; not counted as an included human-result report Full text · 2026-10-06T07:55:26.676825Z
- Acute Ketone Salts-Caffeine-Taurine-Leucine Supplementation but not Ketone Salts-Taurine-Leucine, Improves Endurance Cycling Performance. Context source; not counted as an included human-result report Abstract only · 2026-10-06T07:55:26.676825Z
- Effects of Caffeine-Taurine Co-Ingestion on Endurance Cycling Performance in High Temperature and Humidity Environments. Abstract only · 2026-10-06T07:55:26.676825Z
- Acute Effects of Taurine Supplementation on Maximal Fat Oxidation and FATmax in Recreational Endurance Runners: A Randomized, Placebo-Controlled, Crossover, and Triple-Blinded Study. Abstract only · 2026-10-06T07:55:26.676825Z
- Effects of taurine combined with caffeine on repetitive sprint exercise performance and cognition in a hypoxic environment. Abstract only · 2026-10-06T07:55:26.676825Z
- Effect of Taurine Combined With Creatine on Repeated Sprinting Ability After Exhaustive Exercise Under Hot and Humid Conditions. Abstract only · 2026-10-06T07:55:26.676825Z
- Does One Shot Work? The Acute Impact of a Single Taurine Dose on Exercise Performance: A Meta-Analytic Review. Context source; not counted as an included human-result report Abstract only · 2026-10-06T07:55:26.676825Z
- Dose-response relationship of taurine on endurance cycling performance under hot and humid conditions. Full text · 2026-10-06T07:55:26.676825Z
- Effects of different doses of taurine supplementation on repeated-sprint performance after exhaustive exercise in a high temperature and humidity environment. Abstract only · 2026-10-06T07:55:26.676825Z
- Acute Effects of Taurine Supplementation on Energy Metabolism and Aerobic Capacity in Physically Active Young Adults. Abstract only · 2026-10-06T07:55:26.676825Z
Reading and assessment notes
This is an AI preliminary assessment, not expert review or formal GRADE. Read the method and common limitations.
Absence of reported harms does not establish safety. This summary does not provide individual treatment or dosing advice.
Data and assessment record
Search coverage for this case
對成人,口服單一牛磺酸相較安慰劑或其他條件相同的同期對照,是否改善實際耐力測驗表現,並有哪些不良反應?急性與長期補充、訓練程度、計時測驗與運動至力竭分層呈現。
Searched:2026-10-06T07:55:26.676825Z · Databases:PubMed
136 records identified; 136 screened; 18 reports included, representing at least 2 study populations. Some relationships remain unresolved.
Some included reports were assessed without full text.
- 部分候選文獻未取得全文,完整偏倚風險與次要結果評讀受限。
- 系統檢索限於 PubMed;未涵蓋所有資料庫與完整引文追查。
Processing record
Evidence summary available
Sources through:2026-10-06 · Generated:2026-10-06T09:22:24.896736+00:00
Retrieved 136 records · Screened 136 · Included 18 reports · Omitted 118
Run:rating-candidate-final-v8
codex_cli / gpt-6.1-sol / problem-search-source-bound-l2+l11-v1
{
"included": 18,
"limits_hit": [
"fulltext_unavailable",
"limited_citation_tracing"
],
"omitted": 118,
"retrieved": 136,
"screened": 136
} sha256:50a0cbe40eade511c8fca99933eb36f9163406ee41cc173233447aebd8fa3279